Earlier, Novo Nordisk A/S (NYSE:NVO) petitioned the FDA to ban compounding pharmacies from producing cheaper, unapproved ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

AstraZeneca and Novo Nordisk are in the firing line for their ... a generic drug for 30 months if a brand-name drug company sues a generic competitor for infringing on an Orange Book-listed ...

A dad died just days after using a weight-loss jab so he could ‘confidently walk his daughter down the aisle’, and now his family are demanding answers. Back in 2022, Tim Ramsay decided he wanted to ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

U.S. regulations allow compounding pharmacies to copy brand-name medicines in short supply by combining, mixing or altering drug ingredients to meet demand. Novo Nordisk's popular weight-loss ...

Novo Nordisk said on Wednesday it is aware of 10 deaths and 100 hospitalizations resulting from people taking compounded ...

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

U.S. regulations allow compounding pharmacies to copy brand-name medicines that are in short supply by combining, mixing or altering drug ingredients to meet demand. Novo Nordisk’s popular ...